Windtree Therapeutics

(OTC) WINT

Current Price$0.02

Market Cap$537.70K

Since IPO (1997)-100%

5 Year-100%

1 Year-98%

1 Month+8%

Windtree Therapeutics Financials at a Glance

Market Cap

$537.70K

Revenue (TTM)

$90.00K

Net Income (TTM)

-$40.00M

EPS (TTM)

-$8.51

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

1.12 (Average)

Dividend

$0.00

Beta (Volatility)

1.12 (Average)

Price

$0.02

Volume

23,736

Open

$0.01

Price

$0.02

Volume

23,736

Open

$0.01

Previous Close

$0.02

Daily Range

$0.01 - $0.02

52-Week Range

$0.01 - $1.86

Estimated Earnings Date

May 29, 2026

Dividend

$0.00

Beta (Volatility)

1.12 (Average)

Price

$0.02

Volume

23,736

Open

$0.01

Previous Close

$0.02

Daily Range

$0.01 - $0.02

52-Week Range

$0.01 - $1.86

Estimated Earnings Date

May 29, 2026

WINT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Windtree Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Jed Andrew Latkin, MBA

Website

www.windtreetx.com

Headquarters

Warrington, PA 18976-3622, US

WINT Financials

Key Financial Metrics (TTM)

Gross Margin

-387.78%

Operating Margin

-37218.89%

Net Income Margin

-44447.78%

Return on Equity

-1302.82%

Return on Capital

-211.70%

Return on Assets

-250.28%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

-1.00%

Stock Overview

Market Cap

$537.70K

Shares Outstanding

33.71M

Volume

23.74K

Avg. Volume

169.02K

Financials (TTM)

Gross Profit

-$349.00K

Operating Income

-$33.50M

EBITDA

-$42.60M

Operating Cash Flow

-$15.12M

Capital Expenditure

$0.00

Free Cash Flow

-$15.12M

Cash & ST Invst.

$204.00K

Total Debt

$12.93M

Windtree Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$360.00K

-183.5%

Gross Margin

0.00%

N/A

Market Cap

$537.70K

N/A

Market Cap/Employee

$38.41K

N/A

Employees

N/A

Net Income

-$28.09M

-921.6%

EBITDA

-$30.83M

-996.7%

Quarterly Fundamentals

Name

Q3 2025YOY CHG

Total Cash

$204.00K

-91.1%

Total Debt

$12.93M

+542.2%

Accounts Receivable

$5.80M

N/A

Inventory

$0.00

N/A

Long Term Debt

$240.00K

-69.4%

Short Term Debt

$12.69M

+932.4%

Return on Assets

-2.50%

N/A

Return on Invested Capital

5.66%

N/A

Free Cash Flow

-$6.37M

+1.1%

Operating Cash Flow

-$6.37M

+1.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

XRTXXORTX Therapeutics Inc.

XRTXXORTX Therapeutics Inc.$2.07-2.42%

VRAXVirax Biolabs Group Limited

VRAXVirax Biolabs Group Limited$3.13+14.23%

DRMADermata Therapeutics, Inc.

DRMADermata Therapeutics, Inc.$1.34-2.90%

ATXIAvenue Therapeutics, Inc.

ATXIAvenue Therapeutics, Inc.$0.31+8.93%

NCELNewcelX Ltd.

NCELNewcelX Ltd.$3.85+0.00%

ELABPMGC Holdings Inc.

ELABPMGC Holdings Inc.$1.18-7.81%

REVBRevelation Biosciences, Inc.

REVBRevelation Biosciences, Inc.$1.08+3.85%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.92-0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.30-0.15%

CLROClearOne

CLROClearOne$6.48+1.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.35-0.05%

ONDSOndas

ONDSOndas$7.41-0.06%

SOFISoFi Technologies

SOFISoFi Technologies$18.24-0.01%

RIVNRivian Automotive

RIVNRivian Automotive$18.63+0.08%

Questions About WINT

What is the current price of Windtree Therapeutics?

Windtree Therapeutics is trading at $0.02 per share.

What is the 52-week range for Windtree Therapeutics?

Over the past 52 weeks, Windtree Therapeutics has traded between $0.01 and $1.86.

How much debt does Windtree Therapeutics have?

As of the most recent reporting period, Windtree Therapeutics reported total debt of $12.93M.

How much cash does Windtree Therapeutics have on hand?

Windtree Therapeutics reported $204.00K in cash and cash equivalents in its most recent financial results.

What is Windtree Therapeutics’s dividend yield?

Windtree Therapeutics does not currently have a dividend yield.

Windtree Therapeutics

Windtree Therapeutics Financials at a Glance

WINT News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Windtree Therapeutics

WINT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Windtree Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About WINT

What is the current price of Windtree Therapeutics?

What is the 52-week range for Windtree Therapeutics?

How much debt does Windtree Therapeutics have?

How much cash does Windtree Therapeutics have on hand?

What is Windtree Therapeutics’s dividend yield?

Premium Investing Services